Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Hearing loss in children with HIV/AIDS.

Buriti AK, Oliveira SH, Muniz LF.

Codas. 2013 Dec 16;25(6):513-520. [Epub ahead of print] English, Portuguese.

2.

Audiologic and vestibular findings in a sample of human immunodeficiency virus type-1-infected Mexican children under highly active antiretroviral therapy.

Palacios GC, Montalvo MS, Fraire MI, Leon E, Alvarez MT, Solorzano F.

Int J Pediatr Otorhinolaryngol. 2008 Nov;72(11):1671-81. doi: 10.1016/j.ijporl.2008.08.002. Epub 2008 Sep 23.

PMID:
18814921
3.

Stavudine, lamivudine and nevirapine combination therapy for treatment of HIV infection and AIDS in adults.

Siegfried NL, Van Deventer PJ, Mahomed FA, Rutherford GW.

Cochrane Database Syst Rev. 2006 Apr 19;(2):CD004535. Review.

PMID:
16625606
4.

Efficacy of zidovudine compared to stavudine, both in combination with lamivudine and indinavir, in human immunodeficiency virus-infected nucleoside-experienced patients with no prior exposure to lamivudine, stavudine, or protease inhibitors (novavir trial).

Joly V, Flandre P, Meiffredy V, Brun-Vezinet F, Gastaut JA, Goujard C, Remy G, Descamps D, Ruffault A, Certain A, Aboulker JP, Yeni P; Novavir Study Group.

Antimicrob Agents Chemother. 2002 Jun;46(6):1906-13.

5.

Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.

Sturt AS, Dokubo EK, Sint TT.

Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008440. doi: 10.1002/14651858.CD008440. Review.

PMID:
20238370
6.

[Clinical importance of tympanometry in the diagnosis of chronic secretory otitis].

Spremo S, Markić Z, Kurbalija.

Srp Arh Celok Lek. 1998 Jul-Aug;126(7-8):242-7. Serbian.

PMID:
9863390
8.

An open randomized controlled trial of zidovudine plus lamivudine versus stavudine plus lamivudine.

Foudraine NA, de Jong JJ, Jan Weverling G, van Benthem BH, Maas J, Keet IP, Jurriaans S, Roos MT, Vandermeulen K, de Wolf F, Lange JM.

AIDS. 1998 Aug 20;12(12):1513-9.

PMID:
9727573
9.

A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study.

García F, Romeu J, Grau I, Sambeat MA, Dalmau D, Knobel H, Gomez-Sirvent JL, Arrizabalaga J, Cruceta A, Clotet BG, Podzamczer D, Pumarola T, Gallart T, O'Brien WA, Miró JM, Gatell JM.

AIDS. 1999 Dec 3;13(17):2377-88.

PMID:
10597779
10.

Expenditures for the care of HIV-infected patients in rural areas in China's antiretroviral therapy programs.

Zhou F, Kominski GF, Qian HZ, Wang J, Duan S, Guo Z, Zhao X.

BMC Med. 2011 Jan 17;9:6. doi: 10.1186/1741-7015-9-6.

11.

A randomized, double-blind study of triple nucleoside therapy of abacavir, lamivudine, and zidovudine versus lamivudine and zidovudine in previously treated human immunodeficiency virus type 1-infected children. The CNAA3006 Study Team.

Sáez-Llorens X, Nelson RP Jr, Emmanuel P, Wiznia A, Mitchell C, Church JA, Sleasman J, Van Dyke R, Richardson CG, Cutrell A, Spreen W, Hetherington S.

Pediatrics. 2001 Jan;107(1):E4.

PMID:
11134468
12.

Slight-mild sensorineural hearing loss in children: audiometric, clinical, and risk factor profiles.

Cone BK, Wake M, Tobin S, Poulakis Z, Rickards FW.

Ear Hear. 2010 Apr;31(2):202-12. doi: 10.1097/AUD.0b013e3181c62263.

PMID:
20054279
13.

Zidovudine and lamivudine: results of phase III studies.

Staszewski S.

J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10 Suppl 1:S57.

PMID:
8595510
14.
15.

Lamivudine in combination with zidovudine, stavudine, or didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group Protocol 306 Investigators.

Kuritzkes DR, Marschner I, Johnson VA, Bassett R, Eron JJ, Fischl MA, Murphy RL, Fife K, Maenza J, Rosandich ME, Bell D, Wood K, Sommadossi JP, Pettinelli C.

AIDS. 1999 Apr 16;13(6):685-94.

PMID:
10397563
16.

Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.

Siegfried N, van der Merwe L, Brocklehurst P, Sint TT.

Cochrane Database Syst Rev. 2011 Jul 6;(7):CD003510. doi: 10.1002/14651858.CD003510.pub3. Review.

PMID:
21735394
17.

A comparison of stavudine plus lamivudine versus zidovudine plus lamivudine in combination with indinavir in antiretroviral naive individuals with HIV infection: selection of thymidine analog regimen therapy (START I).

Squires KE, Gulick R, Tebas P, Santana J, Mulanovich V, Clark R, Yangco B, Marlowe SI, Wright D, Cohen C, Cooley T, Mauney J, Uffelman K, Schoellkopf N, Grosso R, Stevens M.

AIDS. 2000 Jul 28;14(11):1591-600.

PMID:
10983646
18.

Hearing assessment in pre-school children with speech delay.

Psillas G, Psifidis A, Antoniadou-Hitoglou M, Kouloulas A.

Auris Nasus Larynx. 2006 Sep;33(3):259-63. Epub 2006 Jan 18.

PMID:
16420975
19.

Audiometric configurations of hearing impaired children in Hong Kong: implications for amplification.

Yuen KC, McPherson B.

Disabil Rehabil. 2002 Nov 20;24(17):904-13.

PMID:
12519486
20.

The prevalence of hearing impairment in the 6 months-5 years HIV/AIDS-positive patients attending paediatric infectious disease clinic at Mulago Hospital.

Christopher N, Edward T, Sabrina BK, Agnes N.

Int J Pediatr Otorhinolaryngol. 2013 Feb;77(2):262-5. doi: 10.1016/j.ijporl.2012.11.013. Epub 2012 Dec 1.

PMID:
23211665

Supplemental Content

Support Center